- Home
- IRON vs VNET Comparison
IRON vs VNET Comparison
Compare IRON & VNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- VNET
- Stock Information
- Founded
- IRON 2017
- VNET 1999
- Country
- IRON United States
- VNET China
- Employees
- IRON N/A
- VNET N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- VNET Computer Software: Programming Data Processing
- Sector
- IRON Health Care
- VNET Technology
- Exchange
- IRON Nasdaq
- VNET Nasdaq
- Market Cap
- IRON 2.0B
- VNET 2.1B
- IPO Year
- IRON N/A
- VNET 2011
- Fundamental
- Price
- IRON $59.82
- VNET $9.57
- Analyst Decision
- IRON Strong Buy
- VNET Strong Buy
- Analyst Count
- IRON 10
- VNET 4
- Target Price
- IRON $97.80
- VNET $11.20
- AVG Volume (30 Days)
- IRON 301.7K
- VNET 6.6M
- Earning Date
- IRON 11-11-2025
- VNET 08-21-2025
- Dividend Yield
- IRON N/A
- VNET N/A
- EPS Growth
- IRON N/A
- VNET N/A
- EPS
- IRON N/A
- VNET N/A
- Revenue
- IRON N/A
- VNET $1,262,962,115.00
- Revenue This Year
- IRON N/A
- VNET $15.46
- Revenue Next Year
- IRON N/A
- VNET $20.35
- P/E Ratio
- IRON N/A
- VNET $438.43
- Revenue Growth
- IRON N/A
- VNET 17.85
- 52 Week Low
- IRON $30.82
- VNET $2.68
- 52 Week High
- IRON $68.73
- VNET $16.13
- Technical
- Relative Strength Index (RSI)
- IRON 50.30
- VNET 64.26
- Support Level
- IRON $58.59
- VNET $7.68
- Resistance Level
- IRON $61.27
- VNET $8.34
- Average True Range (ATR)
- IRON 2.13
- VNET 0.58
- MACD
- IRON -0.15
- VNET 0.13
- Stochastic Oscillator
- IRON 18.47
- VNET 94.42
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About VNET VNET Group Inc.
VNET started as AsiaCloud in 1999 and moved to the data center business with its first self-developed data center opening in 2010. The firm listed (as 21Vianet) on the Nasdaq in April 2011, subsequently changing its name to VNET Group in 2021. It originally focused on providing data center services such as colocation and cloud services to retail clients in China, but added hyperscale customers in 2019 and now counts large Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud as customers. At the end of June 2025, it had 51,960 retail cabinets with the majority in Beijing, Shanghai, and the Greater Bay area. It also had 674 MW of wholesale capacity in service with a further 326 MW under construction and a further 792 MW held for future development.